Related Experiment Video
Updated: Jun 4, 2025
09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
2.5K
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.
Jasper X Zheng1, Elham Vali Betts1, Denis M Dwyre1
1Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)
|December 17, 2024
Summary
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare cancer. Early diagnosis and prompt treatment are crucial for achieving remission in pediatric BPDCN cases, despite its poor prognosis in adults.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy.
- Diagnostic challenges include its heterogeneity, requiring integrated clinical, morphologic, immunohistochemical, and molecular analyses.
- Optimal management and outcomes for BPDCN remain areas of significant concern.
